Company Quick10K Filing
Axim Biotechnologies
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-08
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-15
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-04-14
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-03-04
10-Q 2013-09-30 Filed 2013-11-18
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-17
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-17
8-K 2020-07-21 Officers, Amend Bylaw, Exhibits
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-05-06
8-K 2020-03-27
8-K 2020-03-17
8-K 2020-01-03
8-K 2019-12-16
8-K 2019-07-02
8-K 2019-05-31
8-K 2019-04-19
8-K 2019-04-02
8-K 2019-02-20
8-K 2019-01-15
8-K 2019-01-02
8-K 2018-11-30
8-K 2018-09-10
8-K 2018-08-21
8-K 2018-05-07
8-K 2018-04-05
8-K 2018-03-30

Axim Biotechnologies Financials

AXIM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Netlist (NLST) 49,311 8% -3.8 -88% 17,046 28,756 25,754 1,987 -15,063 -14,932 57,337
Pilgrim Bancshares (PLRM) 48,672 -255% 7.2 0% 265,062 230,554 66 -168 1,054 4,999 36,220
Invo Bioscience (IVOB) 48,235 90% -44.5 -55% 2,565 6,325 1,152 1,040 -1,410 -1,039 46,225
Axim Biotechnologies (AXIM) 45,833 18% -9.2 -211% 2,377 8,554 513 95 -5,011 -4,838 44,666
Hickok (HICKA) 45,489 22% 4.7 11% 62,836 43,919 89,731 19,505 6,620 10,751 50,895
PayMeOn (PAYM) 45,400 -1,762% -13.7 -131% 2,583 3,294 4 -69 -3,373 -3,295 45,135
Arch Therapeutics (ARTH) 45,130 -9.4 -157% 2,902 3,710 0 0 -4,548 -4,548 42,950
Positive Physicians Holdings (PPHI) 44,543 0% 148.2 -0% 154,581 81,735 20,883 0 -474 174 25,856
Intersections (INTX) 44,437 68% 4.2 25% 37,736 36,881 155,171 105,871 9,357 13,535 56,883
Petroshare (PRHR) 44,347 0% 5.6 -15% 36,928 45,101 16,134 0 -5,501 7,311 40,589
Medicine Man Technologies (MDCL) 44,094 40% -2.1 -38% 35,919 7,979 9,100 3,629 -13,562 -13,517 28,889
Terra Tech (TRTC) 44,034 50% -2.4 -23% 129,806 38,597 25,337 12,769 -29,554 -23,775 57,216
Hoth Therapeutics (HOTH) 44,012 -10.7 -88% 4,335 25 0 0 -3,793 -3,793 40,597
Cosmos Holdings (COSM) 43,856 7% 120.0 -1% 21,280 27,665 36,392 2,689 -183 380 45,596
Gulfslope Energy (GSPE) 43,691 -3.7 -45% 30,784 31,113 0 0 -13,724 -11,439 42,552
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Where Food Comes From (WFCF) 43,107 42% 21.1 4% 19,538 6,989 15,075 6,341 759 1,882 39,712
CCUR (CCUR) 42,638 0% 7.9 6% 65,998 9,965 5,021 0 4,245 4,508 35,471
Smartag International (SMRN) 42,619 100% -140.1 -347% 87 31 1 1 -304 -304 42,532
Mastermind (MMND) 42,338 88% 91.3 16% 2,419 256 3,727 3,297 375 459 41,906

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2339281914010950661195436324,1043,0822,0586321,8062,6622,2081,167
Accounts Receivable1015202015111339
Inventory2359641793107885466
PP&E16111110966543
Assets728758681331269691571,0627382361,8258254,4143,3222,1927922,0893,0182,8822,377
Accounts Payable6
Long-Term Debt462,818
Liabilities627749561381361371421511,2511,3191,2872,5883,7217,8428,1748,4776,9948,1718,3059,0438,554
Stockholders' Equity1010912-5-11-40-51-94-189-581-1,052-763-2,896
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue151515-2111111022194101561793403
Cost of Revenue3339-1213488326
Gross Profit-11-202815313577
R&D13314063633517351533992427
SG&A1615131745111283153765605475871,773857764
Tax0000000000
Net Income-1-02-17-6-300-43-139-392-507-1,704-524-565-1,642-1,438-1,334-2,343-1,805-864
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302014-12-312015-03-312015-09-302017-03-312017-06-302017-09-302017-12-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating6-3611-5-20-4-299-466-581-1,017-1,016-729-1,150-1,751
Cash Investing0-500000000000177
Cash Financing10150500650-4665003,940-6-81,585696533